Fig. 3.
Diagnostic yields for each group. (a) Sanger sequencing strategy (197 patients); (b) next‐generation sequencing (NGS) strategy (99 patients).
Diagnostic yields for each group. (a) Sanger sequencing strategy (197 patients); (b) next‐generation sequencing (NGS) strategy (99 patients).